Assembly Bio said that it plans to advance ABI-1179 directly into the Phase 1b portion of the study, which will include ...

Dedicated findings highlight authID's leadership in fast, frictionless, and accurate processes that do not compromise on ...

Assembly Biosciences (ASMB) announced positive interim Phase 1a results in healthy participants from its ongoing Phase 1a/b study of ABI-1179, ...

Haisco Pharmaceutical Group Co. Ltd. has described Werner syndrome ATP-dependent helicase (WRN; RECQ3; RECQL2) inhibitors reported to be useful for the treatment of cancer.

Ideaya Biosciences ( ($IDYA) ) has released its Q4 earnings. Here is a breakdown of the information Ideaya Biosciences presented to its investors.

Reports Q4 revenue $7M, consensus $4.31M. The net loss for the three months ended December 31, 2024, was $130.3M compared to the net loss of ...

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced financial results for the quarter and full ...

In addition, helicases are required for the replication of infectious viruses. Structural studies of small molecule inhibition of helicase action provide insight into their function as molecular ...

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...